MüV Launches its Phytocannabinoid Blended Topicals Line
Made with the highest quality sourced ingredients, MüV’s first three topicals include a Relief Cream, Hydrating Lotion and Sports Gel.
Sarasota, FL. Aug. 1, 2016 – MüV announced today that three of its products are now available to Americans seeking a full spectrum cannabinoid blend in the form of a natural, high purity topical.
The initial MüV topical line includes industrial hemp-derived CBD only Sports Gel, Body Butter and Rosemary Mint Hydrating Lotion. MüV’s CBD-only topicals can be ordered directly nationwide from muvproducts.com. MüV’s full spectrum cannabinoid topical formulations, including Sports Gel, Rosemary Mint Hydrating Lotion and a Relief Cream, will be available initially through licensed medical marijuana dispensaries in Arizona.
MüV’s CBD-only Sports Gel and CBD body Butter are endorsed by one of the world’s top natural health experts. David “Avocado” Wolfe. With over 22 years of dedicated experience, David has led the environmental charge for radiant health via a positive mental attitude, eco-community building, and the purest quality organic foods and herbs.
“MüV topicals provide the most well-balanced blend of all natural elements to compliment and work with industrial hemp-derived CBD,” Wolfe said.
MüV, is an affiliate of Sarasota Florida’s AltMed LLC whose mission is to produce safe, reliable and effective cannabis based therapies with pharmaceutical level quality and consistency.
“Unlike many players in this industry who were drawn in by potential profits and are now trying to learn on the fly about the rigorous processes required to create safe and consistent therapies, we have decades of experience in the pharmaceutical industry,” said Michael Smullen, MüV CEO and co-founder of AltMed, LLC. “We are bringing pharmaceutical industry standards to our research, science and testing to create the safest, purest and most reliable products on the market.”
All MüV products come with a 100% “Love it or Return it” guarantee. For more information and/or to order MüV products visit muvproducts.com
About MüV – MüV is an affiliate of Alternative Medical Enterprises, LLC. Alternative Medical Enterprises, LLC, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.
Media Contact: Colin Trethewey / PRmediaNow / 813.480.1354 / Colin@PRmediaNow.com